We investigated differences in outcomes between 68 children hospitalized with macrolide-sensitive Mycoplasma pneumoniae pneumonia (MSMP group) and 25 children hospitalized with macrolide-resistant M. pneumoniae pneumonia (MRMP group). In the MRMP group, 19 children received macrolides and clinical failure occurred in six of which five had pneumonia progression during therapy.published_or_final_versio
Background: Mycoplasma pneumoniae is a pneumonia-causing pathogen commonly found in pediatric patien...
Macrolide-resistant Mycoplasma pneumoniae (MRMP) is rapidly emerging in Asia, but information on the...
OBJECTIVES: Mycoplasma pneumoniae is a frequent cause of human lower respiratory tract infections...
We investigated differences in outcomes between 68 children hospitalized with macrolide-sensitive My...
We investigated differences in outcomes between 68 children hospitalized with macrolide-sensitive My...
Background: Mycoplasma pneumoniae is a common pathogen for pneumonia in children, especially in the ...
Mycoplasma pneumoniae is a major causative pathogen of community-acquired pneumonia in children, and...
Abstract Background With the emergence of macrolide resistance, concerns about the efficacy of macro...
SummaryThe development of macrolide resistance that occurred during 3 days of therapy with azithromy...
Background With the emergence of macrolide resistance, concerns about the efficacy ...
Mycoplasma pneumoniae accounts for 10-30% of community-acquired pneumonia (CAP) in children. This st...
AbstractBackgroundThe aim of this study was to clarify retrospectively the characteristics of childr...
PurposeMacrolide resistance rate of Mycoplasma pneumoniae has rapidly increased in children. Studies...
Macrolide-resistant Mycoplasma pneumoniae (MRMP) is highly prevalent in Asia and is now being repo...
A high prevalence rate of macrolide-resistant Mycoplasma pneumoniae (MRMP) has been reported in Asia...
Background: Mycoplasma pneumoniae is a pneumonia-causing pathogen commonly found in pediatric patien...
Macrolide-resistant Mycoplasma pneumoniae (MRMP) is rapidly emerging in Asia, but information on the...
OBJECTIVES: Mycoplasma pneumoniae is a frequent cause of human lower respiratory tract infections...
We investigated differences in outcomes between 68 children hospitalized with macrolide-sensitive My...
We investigated differences in outcomes between 68 children hospitalized with macrolide-sensitive My...
Background: Mycoplasma pneumoniae is a common pathogen for pneumonia in children, especially in the ...
Mycoplasma pneumoniae is a major causative pathogen of community-acquired pneumonia in children, and...
Abstract Background With the emergence of macrolide resistance, concerns about the efficacy of macro...
SummaryThe development of macrolide resistance that occurred during 3 days of therapy with azithromy...
Background With the emergence of macrolide resistance, concerns about the efficacy ...
Mycoplasma pneumoniae accounts for 10-30% of community-acquired pneumonia (CAP) in children. This st...
AbstractBackgroundThe aim of this study was to clarify retrospectively the characteristics of childr...
PurposeMacrolide resistance rate of Mycoplasma pneumoniae has rapidly increased in children. Studies...
Macrolide-resistant Mycoplasma pneumoniae (MRMP) is highly prevalent in Asia and is now being repo...
A high prevalence rate of macrolide-resistant Mycoplasma pneumoniae (MRMP) has been reported in Asia...
Background: Mycoplasma pneumoniae is a pneumonia-causing pathogen commonly found in pediatric patien...
Macrolide-resistant Mycoplasma pneumoniae (MRMP) is rapidly emerging in Asia, but information on the...
OBJECTIVES: Mycoplasma pneumoniae is a frequent cause of human lower respiratory tract infections...